Eaton Vance Worldwide Health Sciences Fund Class A
$15.00
Eaton Vance Worldwide Health Sciences Fund Class A (ETHSX) Forecast
See the Price Targets and Ratings of:
ETHSX Analyst Rating
Strong Buy
41ConsensusRatings
38Buy3Hold0Sell
Based on the Wall Street analyst consensus for 41 of ETHSX’s holdings.
ETHSX Analyst Price Target
Average Price Target
$16.51â–²(10.07% Upside)
Based on Wall Street analyst 12-month price targets for 41 of Eaton Vance Worldwide Health Sciences Fund Class A’s holdings in the last 3 months. The average price target is $16.51 with a high forecast of $19.02 and a low forecast of $12.63. The average price target represents a 10.07% change from the last price of $15.00.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$19.02
Average$16.51
Low$12.63
Past 12 Months12 Month Forecast$11$13.25$15.5$17.75$20Feb2026May2026Aug2026Nov2026Nov2027
What is ETHSX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 41 of ETHSX’s holdings, Eaton Vance Worldwide Health Sciences Fund Class A’s 12-month average price target is $16.51.
What is ETHSX’s upside potential, based on the analysts’ average price target?
ETHSX’s average price target of $16.51 represents a 10.07% upside from its last price of $15.00.
Is ETHSX a Buy, Sell or Hold?
Eaton Vance Worldwide Health Sciences Fund Class A has a consensus rating of Strong Buy, based on the analyst consensus for 41 of ETHSX’s holdings: 38 rated Buy, 3 rated Hold and 0 rated Sell.
What is Eaton Vance Worldwide Health Sciences Fund Class A’s price target?
The average price target for Eaton Vance Worldwide Health Sciences Fund Class A is $16.51, based on Wall Street analyst 12-month price targets for 41 of ETHSX’s holdings, issued in the past 3 months. The highest price target is $19.02 and the lowest is $12.63. The average price target represents a 10.07% increase from the last price of $15.00.
How can I buy shares of ETHSX?
You can buy shares of ETHSX through a brokerage account. Compare brokers on our Best Online Brokers page.